NCT05789823

Brief Summary

Ischemic post-conditioning is a neuroprotective strategy that has been proven to attenuate reperfusion injury in animal models of stroke. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. The purpose of this study is to further determine the efficacy and safety of ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
160

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 29, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

March 26, 2025

Status Verified

March 1, 2025

Enrollment Period

2 years

First QC Date

March 16, 2023

Last Update Submit

March 21, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infarct volume at 24 hours

    Infarct volume on MRI-DWI at 24 hours after randomization

    24 hours after randomization

Secondary Outcomes (12)

  • Progression of infarct volume between baseline and 24 hours

    Baseline and 24 hours after randomization

  • Progression of perfusion defect from baseline to 24 hours

    Baseline and 24 hours after randomization

  • Progression of infarct volume between 2 hours and 24 hours

    2 hours after randomization and 24 hours after randomization

  • Infarct volume at 5 days/at discharge

    5 days after randomization or at discharge

  • The proportion of functional independence at 90 days

    90 days after randomization

  • +7 more secondary outcomes

Other Outcomes (5)

  • Safety outcome (mortality at 90 days)

    90 days after randomization

  • Safety outcome (the proportion of symptomatic intracranial hemorrhage within 24 hours)

    Within 24 hours after randomization

  • Safety outcome (the proportion of intracranial hemorrhage within 24 hours)

    Within 24 hours after randomization

  • +2 more other outcomes

Study Arms (2)

Ischemic post-conditioning group

EXPERIMENTAL

Mechanical thrombectomy combined with ischemic post-conditioning

Procedure: Mechanical thrombectomy combined with ischemic post-conditioning

Control group

SHAM COMPARATOR

Mechanical thrombectomy alone

Procedure: Mechanical thrombectomy alone

Interventions

Ischemic post-conditioning will be applied after successful recanalization of the culprit artery achieve by thrombectomy. Ischemic post-conditioning consists of briefly repeated 4 cycles × 2 minutes of occlusion and reperfusion (equal duration) of the initially occluded artery using a balloon.

Ischemic post-conditioning group

Successful recanalization was achieved by mechanical thrombectomy without subsequent ischemic post-conditioning.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years;
  • Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
  • Previous mRS ≤ 2;
  • Baseline NIHSS ≥ 6;
  • Baseline ASPECTS ≥ 6;
  • Unilateral middle cerebral artery occlusion with or without ipsilateral internal carotid artery occlusion;
  • Successful recanalization after mechanical thrombectomy (eTICI 2b-3);
  • Written informed consent provided by the patients or their legal relatives.

You may not qualify if:

  • Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Complications related to thrombectomy, such as contrast agent extravasation, vascular perforation/rupture, dissection, and escape of thrombus;
  • Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
  • \> 2 times of balloon dilations as rescue therapy due to angioplasty during thrombectomy;
  • Patients with contraindications to MRI;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Huanhu Hospital

Tianjin, Tianjin Municipality, 300350, China

RECRUITING

Related Publications (2)

  • Wu L, Wei M, Zhang B, Zhang B, Chen J, Wang S, Luo L, Liu S, Li S, Ren C, Hess DC, Song H, Zhao W, Ji X. Safety and Tolerability of Direct Ischemic Postconditioning Following Thrombectomy for Acute Ischemic Stroke. Stroke. 2023 Sep;54(9):2442-2445. doi: 10.1161/STROKEAHA.123.044060. Epub 2023 Jul 27.

    PMID: 37497674BACKGROUND
  • Wu L, Zhang B, Zhao W, Ji X, Wei M. Ischemic post-conditioning in acute ischemic stroke thrombectomy: A phase-I duration escalation study. Front Neurosci. 2022 Dec 8;16:1054823. doi: 10.3389/fnins.2022.1054823. eCollection 2022.

    PMID: 36523440BACKGROUND

Related Links

MeSH Terms

Conditions

Ischemic Stroke

Interventions

Ischemic Postconditioning

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Therapeutics

Central Study Contacts

Xunming Ji, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 16, 2023

First Posted

March 29, 2023

Study Start

November 1, 2023

Primary Completion

November 1, 2025

Study Completion

February 1, 2026

Last Updated

March 26, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

Locations